Enrico Orciuolo

Enrico Orciuolo

UNVERIFIED PROFILE

Are you Enrico Orciuolo?   Register this Author

Register author
Enrico Orciuolo

Enrico Orciuolo

Publications by authors named "Enrico Orciuolo"

Are you Enrico Orciuolo?   Register this Author

62Publications

1076Reads

47Profile Views

Tumor dormancy as an alternative step in the development of chemoresistance and metastasis - clinical implications.

Cell Oncol (Dordr) 2019 Aug 7. Epub 2019 Aug 7.

Hematology Unit, Azienda Ospedaliera Universitaria Pisana, 56126, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13402-019-00467-7DOI Listing
August 2019

Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy.

J Hematol Oncol 2018 06 20;11(1):84. Epub 2018 Jun 20.

Department of Clinical and Experimental Medicine, Section of Hematology, Azienda Ospedaliero Universitaria Pisana, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-018-0624-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011351PMC
June 2018

PRDI-BF1 and PRDI-BF1P isoform expressions correlate with disease status in multiple myeloma patients.

Hematol Rep 2017 Dec 22;9(4):7201. Epub 2017 Dec 22.

Department of Clinical and Experimental Medicine, U.O. Hematology, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4081/hr.2017.7201DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5757414PMC
December 2017

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

Endocr Relat Cancer 2015 Aug 22;22(4):545-59. Epub 2015 Jun 22.

Genomic Oncology AreaGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS, Granada, 18016 Granada, SpainHematology DepartmentVirgen de las Nieves University Hospital, Granada, SpainGenomic Epidemiology GroupGerman Cancer Research Center (DKFZ), Heidelberg, GermanyDepartment of BiologyUniversity of Pisa, Pisa, ItalyDepartment of HematologyHospital Universitario Doce de Octubre, Madrid, SpainArea of Genomic MedicineGENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, PTS Granada, Granada, SpainSemmelweis UniversityBudapest, HungaryHaematology DepartmentUniversity Hospital of Salamanca and IBSAL, Salamanca, SpainMedical University of LodzLodz, PolandINSERM UMR 1052/CNRS 5286Université Claude Bernard Lyon I, Lyon, FranceMorales Meseguer General University HospitalMurcia, SpainHaematoloy ClinikHolly Cross Cancer Center, Kielce, PolandINSERMU900, Genetic Epidemiology of Cancers team, Institut Curie, Mines ParisTech, Paris, FranceLife and Health Sciences Research Institute (ICVS)School of Health Sciences, University of Minho, Braga, PortugalICVS/3B's - PT Government Associate LaboratoryBraga/Guimarães, PortugalMolecular Oncology Research CenterBarretos Cancer Hospital, Barretos, BrazilIDIBELL - Catalan Institute of OncologyUniversity of Barcelona, Barcelona 08907, SpainDepartment of HematologyCracow University Hospital, Cracow, PolandOrgan CenterHospital of Southern Jutland, DK-6200 Aabenraa, DenmarkFaculty of Health SciencesInstitute of Regional Health Research, University of Southern Denmark, DK-5000 Odense C, DenmarkUO HematologyDepartment of Internal and Experimental Medicine, University of Pisa, Pisa, ItalyClinic of Biochemistry and ImmunologyLaboratory Center, Hospital of Southern Jutland, Aabenraa, DenmarkDepartment of HaematologyRigshospitalet and Roskilde Hospital, Copenhagen University, Copenhagen, Denmark Genomic Oncology AreaGENYO, Cen

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0029DOI Listing
August 2015

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Cancer Epidemiol Biomarkers Prev 2014 Apr 12;23(4):670-4. Epub 2014 Feb 12.

Authors' Affiliations: Genomic Epidemiology Group, Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Hematology, Cracow University Hospital, Cracow; Medical University of Łodz; Laboratory of Clinical and Transplant Immunology and Genetics, Copernicus Memorial Hospital, Łodz; Rzeszow Regional Hospital, Rzeszow; Holycross Cancer Center, Kielce, Poland; Department of Hematology, Hospital Universitario Doce de Octubre, Madrid; Morales Meseguer General University Hospital, Murcia; University Hospital of Salamanca, Salamanca; Genomic Oncology Area, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government; Hematology Department, Virgen de las Nieves University Hospital, Granada; IDIBELL-Catalan Institute of Oncology, University of Barcelona, Barcelona, Spain; Semmelweis University, Budapest, Hungary; Institut National de la Santé et de la Recherche Medicale (INSERM) UMR 1052/CNRS 5286, Université Claude Bernard Lyon I, Lyon; Genetic Epidemiology of Cancer team, INSERM, U900, Institut Curie, Mines ParisTech, Paris, France; Department of Biology, University of Pisa, Pisa, Italy; Clinic of Immunology, Laboratory Center, Hospital of Southern Jutland, Sønderborg; Organ Center, Hospital of Southern Jutland, Aabenraa; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense C; National Research Centre for the Working Environment, Copenhagen; Roskilde Hospital, Copenhagen University, Roskilde, Denmark; Life and Health Sciences Research Institute, University of Minho, Braga; ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal; UO Hematology, Department of Internal and Experimental Medicine, University of Pisa, Pisa, Italy; and Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-13-1115DOI Listing
April 2014

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

J Nucl Med 2012 Jun 10;53(6):922-7. Epub 2012 May 10.

Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.111.101006DOI Listing
June 2012

2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma.

Leuk Res 2010 Feb 2;34(2):184-9. Epub 2009 May 2.

Department of Oncology, Transplants and Advanced Technologies, Haematology Section, University of Pisa, Ospedale S. Chiara, Via Roma 56, 56126 Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2009.04.003DOI Listing
February 2010

Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myeloma.

Acta Haematol 2009 29;122(1):39-41. Epub 2009 Aug 29.

Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/235819
Publisher Site
http://dx.doi.org/10.1159/000235819DOI Listing
November 2009

MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma.

Acta Haematol 2009 29;122(1):42-5. Epub 2009 Aug 29.

Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/235820
Publisher Site
http://dx.doi.org/10.1159/000235820DOI Listing
November 2009

[Spontaneous rupture of the spleen in non-hodgkin lymphoma: a case report].

Chir Ital 2008 Sep-Oct;60(5):739-44

U.O. di Chirurgia Generale, Ospedale E Lotti, Pontedera, Pisa.

View Article

Download full-text PDF

Source
February 2009

Meningeal relapse in a case of B acute lymphoblastic leukemia: the role of CD56 expression.

Med Sci Monit 2009 Feb;15(2):CS27-29

Division of Hematology, Department of Oncology, Transplants and New Technologies in Medicine, University of Pisa, Pisa, Italy.

View Article

Download full-text PDF

Source
February 2009

Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.

Hematol Oncol 2008 Sep;26(3):179-81

Division of Hematology, Department of Oncology, Transplantations and New Technologies in Medicine, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/hon.849
Publisher Site
http://dx.doi.org/10.1002/hon.849DOI Listing
September 2008

MDR1 diplotypes as prognostic markers in multiple myeloma.

Pharmacogenet Genomics 2008 May;18(5):383-9

Department of Biology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0b013e3282f82297DOI Listing
May 2008

CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.

Leuk Res 2008 Feb 9;32(2):263-7. Epub 2007 Aug 9.

Division of Hematology, Department of Oncology, Transplants and Advanced Technologies in Medicine, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.06.002DOI Listing
February 2008

Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing.

J Orthop Res 2008 Feb;26(2):176-83

Department of Oncology, Transplant and Advanced Technologies in Medicine, Hematology Division, University of Pisa, Via Roma 67, 56126, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jor.20490DOI Listing
February 2008

Association of PIM gene translocation and TEL/AML1 rearrangement.

Leuk Res 2007 Dec 8;31(12):1761-2. Epub 2007 Jun 8.

Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Ospedale S. Chiara, Via Roma, 67, 56100 Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.04.015DOI Listing
December 2007

Stable low IgG levels in relapsed non-Hodgkin's lymphomas.

Ann Hematol 2007 Nov 31;86(11):851-3. Epub 2007 May 31.

Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Ospedale S Chiara, Via Roma, 67, 56100, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-007-0306-6DOI Listing
November 2007

Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.

J Leukoc Biol 2007 Oct 11;82(4):839-48. Epub 2007 Jul 11.

Department of Oncology, Transplant and Advances in Medicine, University of Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.0207090DOI Listing
October 2007

Two cases of plasma cell leukemia with atypical immunophenotype.

Acta Haematol 2007 11;118(1):27-9. Epub 2007 Apr 11.

Department of Oncology, Transplants and Advanced Technologies, Section of Hematology, Pisa University, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000101557DOI Listing
July 2007

Cell death and impairment of glucose-stimulated insulin secretion induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the beta-cell line INS-1E.

Toxicol Appl Pharmacol 2007 May 6;220(3):333-40. Epub 2007 Feb 6.

Dipartimento di Patologia Sperimentale, Biotecnologie Mediche, Infettivologia ed Epidemiologia,Sezione di Patologia Generale, Pisa, Italy.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0041008X0700049
Publisher Site
http://dx.doi.org/10.1016/j.taap.2007.01.017DOI Listing
May 2007

Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy.

Leuk Res 2006 Mar 21;30(3):349-53. Epub 2005 Sep 21.

Department of Oncology, Transplant and Advances in Medicine, Section of Hematology, University of Pisa, Ospedale S. Chiara, Via Roma 56, 56100 Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2005.07.011DOI Listing
March 2006

Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.

Blood 2005 Mar 16;105(6):2258-65. Epub 2004 Nov 16.

Transplant Immunology Section, Department of Blood and Marrow Transplantation, MD Anderson Cancer Center, SCRB 3.3019, Unit 900, 7455 Fannin St, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2004-09-3421DOI Listing
March 2005

Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocythemia.

Leuk Res 2004 Oct;28(10):1097-105

Department of Oncology, Transplants and Advanced Technologies in Medicine, Hematology Division, University of Pisa, Ospedale S Chiara, Via Roma 67, Pisa, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2004.01.019DOI Listing
October 2004